Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Haloperidol Versus Ondansetron for Cannabis Hyperemesis Syndrome (HaVOC): A Randomized Controlled Trial

NCT03056482 is registered in ClinicalTrials.gov with Dr. Marco L.A. Sivilotti as lead sponsor.

NCT NCT03056482
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03056482 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Haloperidol Versus Ondansetron for Cannabis Hyperemesis Syndrome (HaVOC): A Randomized Controlled Trial
Lead sponsor
Dr. Marco L.A. Sivilotti
Phase
Phase 4
Overall status
Completed
Start date
May 21, 2017
Completion date
July 7, 2019
Enrollment
33 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

cannabis use disorder